4.3 Article

Chromatography Process Development in the Quality by Design Paradigm I: Establishing a High-Throughput Process Development Platform as a Tool for Estimating Characterization Space for an Ion Exchange Chromatography Step

期刊

BIOTECHNOLOGY PROGRESS
卷 29, 期 2, 页码 403-414

出版社

WILEY
DOI: 10.1002/btpr.1705

关键词

quality by design (QbD); high throughput process development (HTPD); PreDictor plates; ion exchange chromatography (IEX); design of experiments (DOE); granulocyte colony stimulating factor (GCSF)

资金

  1. Department of Biotechnology, Government of India, New Delhi
  2. GE Healthcare (Uppsala, Sweden)

向作者/读者索取更多资源

This article describes the development of a high-throughput process development (HTPD) platform for developing chromatography steps. An assessment of the platform as a tool for establishing the characterization space for an ion exchange chromatography step has been performed by using design of experiments. Case studies involving use of a biotech therapeutic, granulocyte colony-stimulating factor have been used to demonstrate the performance of the platform. We discuss the various challenges that arise when working at such small volumes along with the solutions that we propose to alleviate these challenges to make the HTPD data suitable for empirical modeling. Further, we have also validated the scalability of this platform by comparing the results from the HTPD platform (2 and 6 L resin volumes) against those obtained at the traditional laboratory scale (resin volume, 0.5 mL). We find that after integration of the proposed correction factors, the HTPD platform is capable of performing the process optimization studies at 170-fold higher productivity. The platform is capable of providing semi-quantitative assessment of the effects of the various input parameters under consideration. We think that platform such as the one presented is an excellent tool for examining the characterization space and reducing the extensive experimentation at the traditional lab scale that is otherwise required for establishing the design space. Thus, this platform will specifically aid in successful implementation of quality by design in biotech process development. This is especially significant in view of the constraints with respect to time and resources that the biopharma industry faces today. (c) 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 403414, 2013

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据